Roche buys U.S. gene sequencing tech company Stratos Genomics

Business News


FILE PHOTO: General view of the Roche building in Welwyn Garden City, following the outbreak of the coronavirus disease (COVID-19), Welwyn Garden City, Britain, May 14, 2020. REUTERS/Paul Childs

ZURICH (Reuters) – Pharmaceutical group Roche (ROG.S) has acquired U.S.-based Stratos Genomics to further develop DNA-based sequencing for diagnostic use, it said on Friday.

“The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion,” the Swiss drug maker said in a statement. “The Roche nanopore sequencer, once developed, will utilise a novel approach that combines electronic and biological components to sequence DNA for fast, flexible and cost-effective clinical diagnostic testing.”

You Might Like

Financial details of the agreement were not disclosed.

Reporting by Brenna Hughes Neghaiwi; editing by Thomas Seythal


Read the Original Article Here

Articles You May Like

Column: Biden’s Gushy Lunch with Thomas Friedman
‘What Is Wrong With’ Us? CBS Pushes Sweeping Bans on All Handguns, Rifles
Elon Musk Says The Left Is ‘Brewing Attacks’ Against Him
‘I dare you to run the same poll with your followers’: Elon Musk polls people about whether they trust politicians or billionaires less, then challenges AOC to do the same
Stocks making the biggest moves midday: Dick’s Sporting Goods, Nordstrom, Wendy’s and more

Leave a Reply

Your email address will not be published.